Study of the predominant vascular postsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed rats.
Horváth
E
E
Institute for Drug Research, Budapest, Hungary.
Bódi
I
I
Jaszlits
L
L
Rabloczky
G
G
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D003655:Decerebrate State; D004146:Dioxanes / Q000494:pharmacology*; D004147:Dioxins / Q000494:pharmacology*; D004285:Dogs; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D011724:Pyridazines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013569:Synapses / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D004147:Dioxins; D011724:Pyridazines; C064892:GYKI 12743